Overcoming EHR-to-EDC Implementation Challenges in Oncology Trials
This webinar will cover how automated data transfer via EHR-to-EDC technology in oncology clinical trials reduces data management burden and enhances overall efficiency, and how sponsors, sites, and technology providers can navigate early adoption.
Registration is complimentary and required to attend.
About this webinar:
Clinical research site staff are facing an overwhelming amount of data collection per study and inefficiencies in transferring that data from electronic health records (EHRs) into electronic data capture (EDC) systems.
Automated EHR-to-EDC technology reduces the data management burden for sites and increases the speed at which that data is available for sponsors, but change management and site buy-in remain critical to scale the use of these tools.
This webinar will unpack the feasibility and impact of automated EHR-to-EDC tools for modern oncology trials, address why sites and sponsors should adopt EHR-to-EDC and navigate the necessary change management for early adoption and implementation, explore how Flatiron supports our research network with tech implementations, and offer participants the chance to ask about Sanofi's experiences working with sites to implement EHR-to-EDC tech during a panel Q&A.
Specifically, attendees will walk away better understanding:
- How EHR-to-EDC improves data capture in oncology trials
- Criteria for assessing automated EHR-to-EDC feasibility in oncology trials
- How leaders at Sanofi and Flatiron support implementation, adoption, and change management internally and alongside research sites partners
This webinar is intended for the pharma R&D industry, particularly those in the following areas, but all are welcome to attend:
VP/Director of Clinical Operations, VP/Director of Clinical Development, VP/Director of Innovation, VP/Director of Site Management or Site Oversight, VP/Director of Data Operations
In this webinar:
- Dawn Snow, Clinical Trial Operations Manager (CTOM), Genzyme, a Sanofi company
- Mariel Boyd, Director, Product Management, Flatiron Health
- Emily Akin, Head of Research Network, Flatiron Health
About Flatiron Health:
Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group.
About DPHARM, the webinar’s associated conference:
DPHARM®: Disruptive Innovations to Modernize Clinical Research offers an unparalleled opportunity to hear senior clinical operation executives and innovative thought leaders unveil the latest innovations to modernize clinical trials and reduce patient burden. The concept of DPHARM was founded by Pfizer and Janssen, who continue to play a key role on the steering committee to deliver a highly relevant and engaging program. Visit DPHARMconference.com for more information.
Registration is complimentary and required to attend.
